StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
ADMA Biologics, Inc.
NasdaqGM:ADMA
Sector
Location
Market Cap
USD 3.99 B
Share Price
USD 16.73
Avg Daily Volume
3,567,826
Change (1 day)
-4.89%
Change (1 year)
28.20%
Change (YTD)
-2.45%
ADMA Biologics, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 34.46%
ADMA Biologics, Inc. EBITDA Margin is 34.46% for the Trailing 12 Months (TTM) ending March 31, 2025, a 252.31% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
ADMA Biologics, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 9.78%, a -198.16% change year over year.
-
ADMA Biologics, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -9.96%, a -84.17% change year over year.
-
ADMA Biologics, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -62.95%, a -47.86% change year over year.
-
ADMA Biologics, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -120.74%, a 5.96% change year over year.
Competitors
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Lonza Group AG
USD 710.43
LONN.SW
+2.77
0.39%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Ucb S.A.
USD 203.26
UCB.BR
+1.51
0.75%
BeOne Medicines Ltd.
USD 294.55
ONC
+4.20
1.45%
Hansoh Pharmaceutical Group Company Limited
USD 4.59
3692.HK
+0.20
4.51%
Summit Therapeutics Inc.
USD 26.20
SMMT
-1.43
-5.18%
Insmed Incorporated
USD 102.56
INSM
-1.61
-1.55%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Lonza Group AG
USD 710.43
LONN.SW
+2.77
0.39%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Ucb S.A.
USD 203.26
UCB.BR
+1.51
0.75%
BeOne Medicines Ltd.
USD 294.55
ONC
+4.20
1.45%
Hansoh Pharmaceutical Group Company Limited
USD 4.59
3692.HK
+0.20
4.51%
Summit Therapeutics Inc.
USD 26.20
SMMT
-1.43
-5.18%
Insmed Incorporated
USD 102.56
INSM
-1.61
-1.55%